VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge
VSee Health (Nasdaq:VSEE) announced FedRAMP Moderate authorization and integration of ICU robotic assistance to enable remote clinician monitoring and intervention in intensive care units. The company reported a 150% year-over-year increase in enterprise deployments and cited recent contract wins, including an agreement to expand public mental health services in a large U.S. county. VSee highlighted platform features like omni-channel visits and EHR integrations and said pipeline partnerships could add millions in recurring revenue by Q2 2026. The release cites a U.S. telehealth market projection of $52.76 billion in 2025 with a 23.84% CAGR through 2034.
VSee Health (Nasdaq:VSEE) ha annunciato l'autorizzazione FedRAMP Moderate e l'integrazione dell'assistenza robotica in terapia intensiva per consentire il monitoraggio e l'intervento remoto dei clinici nelle unità di terapia intensiva. L'azienda ha riportato un aumento del 150% su base annua delle implementazioni aziendali e ha citato recenti vincite contrattuali, tra cui un accordo per espandere i servizi pubblici di salute mentale in una vasta contea degli Stati Uniti. VSee ha evidenziato caratteristiche della piattaforma come visite omni‑channel e integrazioni EHR e ha detto che le partnership nel pipeline potrebbero aggiungere milioni di entrate ricorrenti entro il secondo trimestre del 2026. Il comunicato cita una proiezione del mercato statunitense della telemedicina di $52,76 miliardi nel 2025 con una TCAC del 23,84% fino al 2034.
VSee Health (Nasdaq:VSEE) anunció la autorización FedRAMP Moderate y la integración de la asistencia robótica en UCIs para permitir la supervisión e intervención remota de clínicos en unidades de cuidados intensivos. La empresa reportó un aumento interanual del 150% en implementaciones empresariales y citó recientes victorias de contratos, incluida un acuerdo para ampliar los servicios de salud mental pública en un gran condado de EE. UU. VSee destacó características de la plataforma como visitas omnicanal y integraciones con EHR y afirmó que las asociaciones de la canalización podrían agregar millones en ingresos recurrentes para el segundo trimestre de 2026. El comunicado cita una proyección del mercado de telemedicina de EE. UU. de $52,76 mil millones en 2025 con un TCAC del 23,84% hasta 2034.
VSee Health (나스닥:VSEE)는 FedRAMP Moderate 인증과 ICU 로봇 보조 기능의 통합을 발표하여 중환자실에서 원격 임상 모니터링 및 개입이 가능해졌다고 밝혔습니다. 회사는 기업용 배치가 연간 150% 증가를 보고했으며, 미국 대도시 카운티에서 공공 정신 건강 서비스 확장을 포함한 최근 계약 체결을 인용했습니다. VSee는 옴니채널 방문 및 EHR 통합과 같은 플랫폼 기능을 강조했고 파이프라인 파트너십이 2026년 2분기까지 재발생 수익 수백만 달러를 추가할 수 있다고 말했습니다. 발표에는 미국 원격의료 시장이 2025년 52.76억 달러로 전망되며 2034년까지 연평균성장률(CAGR) 23.84%를 보인다고 명시되어 있습니다.
VSee Health (Nasdaq:VSEE) a annoncé l'autorisation FedRAMP Moderate et l'intégration de l'assistance robotisée en UCD pour permettre la surveillance et l'intervention à distance des cliniciens dans les unités de soins intensifs. L'entreprise a reporté une augmentation de 150 % d'une année sur l'autre des déploiements d'entreprise et a cité des victoires récentes de contrats, y compris un accord visant à étendre les services de santé mentale publique dans un grand comté américain. VSee a mis en évidence des fonctionnalités de la plateforme telles que les visites omnicanales et les intégrations EHR et a déclaré que les partenariats de pipeline pourraient ajouter des millions de revenus récurrents d'ici le deuxième trimestre 2026. Le communiqué cite une projection du marché américain de la télésanté de 52,76 milliards de dollars en 2025 avec un TCAC de 23,84 % jusqu'en 2034.
VSee Health (Nasdaq:VSEE) gab FedRAMP Moderate-Zustimmung und die Integration der roboterbasierten Unterstützung in der Intensivmedizin bekannt, um remote Überwachung und Intervention durch Kliniker auf Intensivstationen zu ermöglichen. Das Unternehmen meldete einen 150%-igen Anstieg der Unternehmensbereitstellungen im Jahresvergleich und verwies auf jüngste Vertragsabschlüsse, darunter eine Vereinbarung zur Erweiterung öffentlicher psychischer Gesundheitsdienste in einem großen Landkreis in den USA. VSee hob Plattformfunktionen wie Omni-Channel-Besuche und EHR-Integrationen hervor und sagte, dass Pipeline-Partnerschaften Millionen an wiederkehrenden Einnahmen bis Q2 2026 hinzufügen könnten. Die Veröffentlichung zitiert eine US-Telemedizin-Marktprognose von $52,76 Milliarden im Jahr 2025 mit einer 23,84%-CAGR bis 2034.
VSee Health (ناسداك: VSEE) أعلنت عن تفويض FedRAMP Moderate ودمج المساعدة الروبوتية في وحدات العناية المركزة لتمكين المراقبة والتدخل عن بُعد من قبل الأطباء في وحدات العناية المركزة. وأبلغت الشركة عن زيادة بنسبة 150% على أساس سنوي في نشرات المؤسسة وأشارت إلى أحدث عقود الفوز، بما في ذلك اتفاقية لتوسيع خدمات الصحة النفسية العامة في مقاطعة كبيرة بالولايات المتحدة. سلطت VSee الضوء على ميزات المنصة مثل الزيارات متعددة القنوات وتكاملات السجلات الصحية الإلكترونية وقالت إن شراكات خطوط الإنتاج قد تضيف ملايين الدولارات من الإيرادات المتكررة بحلول الربع الثاني من 2026. وتذكر البيان توقع سوق الرعاية الصحية عن بُعد في الولايات المتحدة من $52.76 مليار في 2025 مع معدل نمو مركب سنوي قدره 23.84% حتى 2034.
- FedRAMP Moderate authorization enables federal sales
- 150% YoY increase in enterprise deployments
- ICU robotic integration enables remote critical-care interventions
- Recent contract to expand public mental health services
- Pipeline revenue described as "could add millions by Q2 2026" and is prospective
- Growth narrative cites large market projections ($52.76B) that are external estimates
Insights
FedRAMP Moderate plus ICU robotics and reported deployment growth materially strengthen federal and enterprise revenue prospects.
VSee Health gains a concrete procurement advantage with FedRAMP Moderate authorization, which explicitly allows its platform to compete for federal agency workloads and related contracts. The company also reports a
Integrating ICU robotics ties the telehealth platform to higher-acuity workflows where real-time monitoring and intervention matter; this expands addressable use cases beyond routine visits. The firm links these product capabilities to a large U.S. market opportunity, quoted at
Key dependencies and risks include successful federal procurement wins, winning and scaling county-level deployments into repeatable programs, and proving clinical and operational integration for ICU robotics in live settings. Watch for awarded federal contract notices, revenue recognition in upcoming quarters, and any disclosed recurring revenue figures by
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units (ICUs), enabling remote clinicians to monitor and intervene in real-time - potentially transforming critical care delivery. Building on its revenue growth and balance sheet strengthening, VSee's innovations align perfectly with the exploding U.S. telehealth market, projected to hit
"Telehealth isn't just convenient anymore; it's essential for saving lives and bending the healthcare cost curve," said Dr. Imo Aisiku , Co-CEO of VSee Health. "Our FedRAMP milestone opens doors to massive government contracts. We're not chasing trends - we're defining them, delivering measurable ROI for enterprises and better outcomes for patients. Recent contract wins, including a contract to expand public mental health services in one of the nation's largest counties, underscore VSee's momentum."
Dr. Aisiku adds, "One remote stroke intervention can save a patient from permanent disability. Multiply that by thousands of understaffed ICUs, and you see the scale of impact we're driving."
The company's platform now supports omni-channel visits, plug-and-play remote exams, and seamless EHR integrations, making it the go-to solution for health systems, payers, and federal entities alike.
This dual-pronged strategy - FedRAMP readiness plus ICU robotics - comes as VSee reports a
About VSee Health
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. Visit vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health, Inc.
View the original press release on ACCESS Newswire
FAQ
What does VSee's FedRAMP Moderate authorization mean for VSEE stock?
How significant is VSee's 150% year-over-year enterprise deployment growth for VSEE (Nasdaq:VSEE)?
What is the timeline for VSee's expected recurring revenue boost by Q2 2026 for VSEE?
How will VSee's ICU robot integration affect patient care and VSEE's market position?
Does VSee have any announced government contracts relevant to VSEE's growth?
What market size supports VSee's 2025 growth claims for VSEE?
